tbuckley/cabot-search huggingface dataset:
DIPG-69. CHARACTERISTICS OF PATIENTS ≥ 10 YEARS OF AGE WITH DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE INTERNATIONAL DIPG REGISTRY
Authors: Craig Erker, Adam Lane, Brooklyn Chaney, Nancy Yanez Escorza, Christine Fuller, Raya Saab, Mark Kieran, Roger Packer, Javad Nazarian, Jane Minturn, Andrew Dodgshun, Sarah Parkin, Nicholas Foreman, Emmett Broxson, Mercedes Garcia Lombardi, Stewart Goldman, Eric Sandler, Kathy Warren, Robert Greiner, Nickolas Gottardo, Hetal Dholaria, Chie-Schin Shih, Tim Hassall, Jordan R Hansford, Shiqi Stacie Wang, Yvan Samson, Sarah Leary, Jie Ma, Ute Bartels, Alberto Broniscer, Michelle Monje, Paul Fisher, David Ziegler, Lars Wagner, Carl Koschmann, Renee Doughman, Rachid Drissi, Blaise Jones, James Leach, Peter White, Phillip Dexheimer, Jacob Hendershot, Cynthia Hawkins, Pratiti Bandopadhayay, Maryam Fouladi
Journal: Neuro-Oncology (2018)

Patients ≥10 years of age with a DIPG are reported to have a higher rate of long-term survival (≥24 months). The purpose of this study was to compare clinical, radiological, pathological and molecular characteristics between patients ≥10 years old with DIPG who were long-term survivors (LTS) vs short-term survivors (STS) and assess biological differences in this age group compared to patients <10 years old. Data were abstracted from the International DIPG Registry (IDIPGR) for patients ≥10 years old at diagnosis. Imaging was reviewed and those with typical radiographic findings of DIPG were included. The primary outcome was overall survival (OS) categorized as LTS (≥24 months) or STS (<24 months). Among 782 patients with abstracted data in the IDIPGR, 170 were ≥10 years of age (22%). The median age and OS [range] were 12.5 [10.0–26.8] years and 15 [2–82] months, respectively; 12.8% were LTS. Biopsy or autopsy were performed in 38% of patients; 83% of patients were H3 K27M-mutant. LTS were found to have longer symptom duration before presentation, lower WHO grade and larger tumor size compared to STS. WGS and RNA sequencing are being conducted. The rate of LTS in patients ≥10 years of age is approximately 13%. Preliminarily, clinical and imaging parameters associated with LTS in this population are similar to general DIPG cohorts. Biological data will be presented for the approximately 38% of patients with available tissue to delineate potential predictors of outcome.
Shall The Journal be Removed to Washington?
Journal: JAMA (1891)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
ONE WORLD
Journal: JAMA (1968)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Hospital clinical information system ensures patient privacy
Journal: BMJ (1999)

Alcohol misusers reduce risks of surgery if they stop drinkingDuring recent years several studies have shown that alcohol misusers who drink at least five drinks a day have increased postoperative morbidity.On p 1311 Tønnesen et al report the results of the first randomised study of an intervention to reduce this morbidity-that is, one month of abstinence from alcohol (controlled with disulfiram) before surgery for colorectal resection.They found that the intervention group experienced a reduced rate of complications after the operation, possible because of improved organ function and reduced responses to surgical stress.The authors recommend preoperative assessment of alcohol misuse and withdrawal for one month before operation.
TRANSMISSION OF TUBERCULOSIS.
Journal: JAMA (1899)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Data Errors in Figure 3 and Labels Transposed in Figure 4
Journal: JAMA (2018)

Lisa M. Askie, PhD; Brian A. Darlow, MD; Neil Finer, MD; Barbara Schmidt, MD; Ben Stenson, MD; William Tarnow-Mordi, MBChB; Peter G. Davis, MD; Waldemar A. Carlo, MD; Peter Brocklehurst, MBChB; Lucy C. Davies, MSc; Abhik Das, PhD; Wade Rich, BSHS; Marie G. Gantz, PhD; Robin S. Roberts, MSc; Robin K. Whyte, MB; Lorrie Costantini, BA; Christian Poets, MD; Elizabeth Asztalos, MD; Malcolm Battin, MD; Henry L. Halliday, MD; Neil Marlow, DM; Win Tin, MBBS; Andrew King, BA; Edmund Juszczak, MSc; Colin J. Morley, MD; Lex W. Doyle, MD; Val Gebski, MSc; Kylie E. Hunter, MPH; Robert J. Simes, MD; for the Neonatal Oxygenation Prospective Meta-analysis (NeOProM) Collaboration
Acute monarticular arthritis following patellar metastasis. A manifestation of carcinoma of the lung
Authors: E. P. Gall
Journal: JAMA (1974)

METASTATIC neoplasm to the patella is unusual, and a monarticular arthritis related to such a lesion appearing as the initial sign of a previously unrecognized carcinoma must be rare indeed. In most cases of arthritis associated with malignant neoplasms, the underlying tumor is evident. We describe a patient with monarticular arthritis secondary to metastatic patellar spread of bronchogenic carcinoma as the earliest symptom of his primary tumor. <h3>Report of a Case</h3> A 63-year-old man was admitted to the hospital for evaluation of arthritis in the left knee. The patient had been initially hospitalized at a sanatorium in 1968 for suspected pulmonary tuberculosis; sputum cultures were negative. In spite of this, he received triple antituberculous drug therapy for one year. Three months before his final admission, he noted pain in the left knee, following a fall. The knee became increasingly swollen until he was unable to bear weight. Chest x-ray films
THE ARMY MEDICAL DEPARTMENT.V. MEDICAL SUPPLY TABLES FOR THE ARMY.
Journal: JAMA (1904)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
SOME FEATURES OF INTESTINAL OBSTRUCTION
Journal: JAMA (1928)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
What and when is death?
Journal: JAMA (1968)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Recovery of the Gut Microbiota after Antibiotics Depends on Host Diet, Community Context, and Environmental Reservoirs
Authors: Katharine Michelle Ng, Andrés Aranda-Díaz, Carolina Tropini, Matthew Ryan Frankel, William Van Treuren, Colleen T. O’Loughlin, Bryan Douglas Merrill, Feiqiao Brian Yu, Kali M. Pruss, Rita Almeida Oliveira, Steven Kyle Higginbottom, Norma F. Neff, Michael Andrew Fischbach, Karina Bivar Xavier, Justin Laine Sonnenburg, Kerwyn Casey Huang
Journal: Cell Host & Microbe (2020)
MEDICARE: THEORY AND PRACTICE
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Herpes Simplex Infection at Term
Authors: Sidney Kibrick
Journal: JAMA (1980)

LITTLE has been published regarding infection control procedures for the woman with an active herpetic infection at term, or for her newborn infant. As yet, no authoritative body has addressed itself to these points in generally available journals. There is also no current agreement on the criteria for cesarean section in the woman with genital herpes infection at term and no uniform policy for managing nursery personnel with herpetic lesions on exposed body surfaces. That guidelines are needed is apparent from numerous requests to our unit for advice on dealing with such problems. In this article, the risks to the newborn arising from herpetic infection in the mother at term are considered and the possible role of cesarean section in minimizing these risks is reviewed. Based on these data, recommendations for treating such mothers are made. In addition, we suggest infection control procedures for the mothers, their newborns, and for
EFFECT OF VITAMIN C DEFICIENCY ON HEALED WOUNDS
Journal: JAMA (1953)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Home Treatment for Catarrhs and Colds.
Journal: JAMA (1894)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Mergers
Journal: JAMA (2001)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Interactions between Selenium Compounds and Those of Mercury or Cadmium
Authors: J. Parizek
Journal: Environmental Health Perspectives (1978)

Two types of mechanisms are considered in this discussion of the interactions between compounds of selenium and those of cadmium or mercury: one based on a direct chemical reaction between compounds of these elements and the other based on metabolic changes induced by selenium administration and modifying the dose-effect relationship indirectly, without a reaction between selenium and the metallic compound. The second type of metabolic changes induced by selenium may explain why an increased selenium intake provides protection not only against methylmercury but also against the toxicity of methylated selenium compounds. A better understanding of the underlying mechanisms would help in assessing the importance of these interactions for man.
Cervical cytology and reimbursement issues
Journal: JAMA (1990)

<h3>In Reply. —</h3> In her response to our recent article, Dr Andrianopoulos suggests that depression may be a risk factor for a subgroup of cancers that are sensitive to immunodeficiency. We did not present analyses by site or type of cancer because we did not have sufficient numbers of cases to conduct conclusive analyses. Of the 637 cases of any diagnosis of cancer, only 71 (11%) were of the types specified by Dr Andrianopoulos. Most of these (47) were carcinomas of the lip and skin. New proportional hazards analyses, with and without adjustment for standard risk factors, showed no significant association between depressive symptoms on the General Well-being Schedule and these types of cancer (relative risk, 1.1), nor was there a significant association when the Center for Epidemiological Studies Depression scale was examined. Even with the small number of cases in these analyses, it appears fair to conclude that if
Long-term use of anticoagulants in private practice
Authors: M. H. Reinberg
Journal: JAMA (1965)

THE EFFICACY of anticoagulants in the treatment of myocardial infarction and in the postinfarction period is controversial.<sup>1</sup>However, it appears likely that such therapy will be used for some time. The risks of anticoagulant therapy are relatively small, as determined in many well-controlled studies.<sup>2 -4</sup>The most important risk is major hemorrhage, the incidence of which was found to be 1.5% to 10% in both short<sup>2,3</sup>and long-term<sup>4,5</sup>usage. Most of the studies have been done in large medical centers. There have been very few reports from private practice, where the incidence of serious hemorrhage may be different. Pastor et al have suggested<sup>5</sup>that the statistics in well-controlled studies may not reflect the true incidence of hemorrhage or fatality, since the practicing physicians who administer most of the anticoagulants do not have occasion to publish their results. One of the most important factors in determining
First-Line Abemaciclib Effective in ER+ Breast Cancer
Journal: Cancer Discovery (2017)

Interim data from the MONARCH3 study indicate that abemaciclib is an effective first-line therapy for advanced ER-positive, HER2-negative breast cancer. Adding the investigational CDK4/6 inhibitor to letrozole significantly improved patients' progression-free survival, compared with those given a placebo alongside endocrine therapy.
A NEWSPAPER FOR THE NERVOUS.HOW NOT TO BE NERVOUS.
Journal: JAMA (2002)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal